OSE Immunotherapeutics

📍 NANTES, France🗓 Founded 2012👥 81 employees💰 Last funded Sep 2025
Biotechnology Research🌐 ose-immuno.com
Website LinkedIn
OSE Immunotherapeutics, a biotech dedicated to developing first-in-class assets in immuno-oncology (IO) & immuno-inflammation (I&I). • Tedopi® (therapeutic cancer vaccine): Registration Phase 3 in 2nd-line NSCLC in HLA-A2+ patients with secondary resistance. Phase 2 trials, sponsored by onco groups, of Tedopi® in combo in solid tumors. • Lusvertikimab (mAb IL-7R antagonist); Positive Phase 2 in UC; preclinical research in ALL. • OSE-279 (anti-PD1): 1st positive results in Phase 1/2 in solid tumors. • FR-104/VEL-101 (anti-CD28 mAb): developed in partnership with Veloxis in transplant; Phase 1/2 in renal transplant (CHU Nantes); successful Phase 1 in the US (Veloxis). • Anti-SIRPα mAb developed in partnership with Boehringer Ingelheim in advanced solid tumors & cardiovascular-renal-metabolic diseases; positive Phase 1 dose escalation results in monotherapy and combo; Phase 2 in CRM diseases planned end 2024. • ABBV-230 (ChemR23 agonist mAb) developed in partnership with AbbVie in chronic inflammation. 4 proprietary drug discovery platforms • Pro-resolutive mAb platform • Myeloid Checkpoint platform • BiCKI® Platform • mRNA Therapeutic platform f
3
Total investors
0
Early stage
0
Mid stage
1
Late stage
2012
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
France
2
Belgium
1
Investor activity2021–2025 · investors recorded per year
202112024120251
Recent (last 2y)Earlier
Frequently asked questions
Who invested in OSE Immunotherapeutics?
OSE Immunotherapeutics has 3 investors on record on gritt.io and 1 late-stage investors.
When did OSE Immunotherapeutics last raise funding?
The most recent investment in OSE Immunotherapeutics recorded on gritt.io was in September 2025.
When was OSE Immunotherapeutics founded?
OSE Immunotherapeutics was founded in 2012.
What industry is OSE Immunotherapeutics in?
OSE Immunotherapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is OSE Immunotherapeutics based?
OSE Immunotherapeutics is headquartered in NANTES, France.